Sanofi

Sanofi and Regeneron Announce Positive Dupixent® (dupilumab) Phase 3 Atopic Dermatitis Data Published in The New England Journal of Medicine

Medical, Pharmaceuticals, Press Releases, Sanofi

Data to be presented today during a late breaking abstract session at the 25th Annual European Academy of Dermatology and Venereology (EADV) Congress Paris, France and Tarrytown, N.Y. (October 1, 2016) – Sanofi and Regeneron Pharmaceuticals, Inc. today announce that detailed results from LIBERTY AD SOLO 1 and SOLO 2, two placebo-controlled Phase 3 studies […]

Sanofi and Regeneron Present Positive Phase 3 Investigational Data for Praluent® (alirocumab) Injection in Patients Undergoing LDL Apheresis Therapy at ESC Congress 2016

Medical, Pharmaceuticals, Press Releases, Regeneron, Sanofi

ODYSSEY ESCAPE data concurrently published in the European Heart Journal Paris, France and Tarrytown, New York – August 29, 2016 – Sanofi and Regeneron Pharmaceuticals, Inc. today announced detailed positive results from ODYSSEY ESCAPE, a Phase 3 trial which evaluated Praluent® (alirocumab) Injection in patients with an inherited form of high cholesterol known as heterozygous […]

Sanofi to Collaborate with Google Life Sciences to Improve Diabetes Health Outcomes

Pharmaceuticals, Sanofi

Will work together on new digital technology and tools for diabetes Aim to use data and miniaturized technology to provide patients with more tools to self-manage their disease, healthcare professionals with the ability to better support and treat patients Strive to shift from episodic, event-driven diabetes care to continuous, value-based care PARIS and MOUNTAIN VIEW, […]

American Diabetes Association Announces Research Award Recipients

Diabetes, Medical, Pharmaceuticals, Press Releases, Sanofi

Pathway to Stop Diabetes will provide funding for innovative diabetes researchers Alexandria, VA (January 9, 2014) – With nearly 26 million adults and children in the U.S. living with diabetes, and another 79 million living with prediabetes, diabetes is a physical and financial burden for the health of the nation. To accelerate the research needed […]

Sanofi and Regeneron Announce Collaboration with American College of Cardiology for PCSK9 Inhibitor Clinical Program

Cardiology, Health, Medical, Pharmaceuticals, Regeneron, Sanofi

– Collaboration represents the first time the ACC’s PINNACLE Registry Research Alliance will be used for clinical trial recruitment – Paris, France and Tarrytown, New York – December 19, 2013 – Sanofi (EURONEXT : SAN and NYSE : SNY) and Regeneron Pharmaceuticals, Inc. (NASDAQ : REGN) announced today an innovative collaboration with the American College […]

New Data Support Flexibility in Timing of Administration for Sanofi’s Lyxumia®